eli lilly news glp-1 says new weight loss pill could reach market in 2026 FDA Approves Eli Lilly's GLP-1

Digestive Upset: Oral users report nausea or bloating following administration

REFERENCES British Menopause Society incretin therapies and HRT NICE tirzepatide guidance NHS England tirzepatide guidance MHRA GLP1 safety guidance Mayo Clinic report on hormone therapy and tirzepatide findings NICE tirzepatide guidance NHS England tirzepatide guidance MHRA GLP1 safety guidance Mayo Clinic report on hormone therapy and tirzepatide findings

Decreased plasma antioxidants in patients with Alzheimers disease

In clinical trials, hair loss was reported in 4-5% of people using tirzepatide (Zepbound) compared to 1% on placebo

L-carnitine also ameliorates oxidative stress by reducing ROS production (43, 47, 75), decreasing hepatic malondialdehyde (MDA) content (30, 59, 76), lowering 8-OHdG concentrations, and attenuating 4-hydroxynonenal (4-HNE) immunostaining intensity (45)